Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse

被引:12
|
作者
Chen, Jihuan [1 ,2 ]
Kawamura, Tomoya [1 ,2 ]
Sethi, Manveen K. [3 ]
Zaia, Joseph [3 ]
Repunte-Canonigo, Vez [1 ,2 ]
Sanna, Pietro Paolo [1 ,2 ]
机构
[1] Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA
[3] Boston Univ, Dept Biochem, Ctr Biomed Mass Spectrometry, Sch Med, Boston, MA 02118 USA
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词
BRAIN REWARD FUNCTION; ACCUMBENS SHELL; IN-VIVO; RECEPTOR; CANCER; OREXIN/HYPOCRETIN; STIMULATION; WITHDRAWAL; INHIBITORS; DOPAMINE;
D O I
10.1038/s41598-017-13960-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Substance abuse is a pressing problem with few therapeutic options. The identification of addiction resilience factors is a potential strategy to identify new mechanisms that can be targeted therapeutically. Heparan sulfate (HS) is a linear sulfated polysaccharide that is a component of the cell surface and extracellular matrix. Heparan sulfate modulates the activity and distribution of a set of negatively charged signaling peptides and proteins - known as the HS interactome - by acting as a co-receptor or alternative receptor for growth factors and other signaling peptides and sequestering and localizing them, among other actions. Here, we show that stimulants like cocaine and methamphetamine greatly increase HS content and sulfation levels in the lateral hypothalamus and that HS contributes to the regulation of cocaine seeking and taking. The ability of the HS-binding neuropeptide glial-cell-line-derived neurotrophic factor (GDNF) to increase cocaine intake was potentiated by a deletion that abolished its HS binding. The delivery of heparanase, the endo-beta-D-glucuronidase that degrades HS, accelerated the acquisition of cocaine self-administration and promoted persistent responding during extinction. Altogether, these results indicate that HS is a resilience factor for cocaine abuse and a novel therapeutic target for the treatment of cocaine addiction.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Target selection of heparan sulfate hexuronic acid 2-O-sulfotransferase
    Smeds, Emanuel
    Feta, Almir
    Kusche-Gullberg, Marion
    GLYCOBIOLOGY, 2010, 20 (10) : 1274 - 1282
  • [42] The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy
    Yang, Yang
    MacLeod, Veronica
    Dai, Yuemeng
    Khotskaya-Sample, Yekaterina
    Shriver, Zachary
    Venkataraman, Ganesh
    Sasisekharan, Ram
    Naggi, Annamaria
    Torri, Giangiacomo
    Casu, Benito
    Vlodavsky, Israel
    Suva, Larry J.
    Epstein, Joshua
    Yaccoby, Shmuel
    Shaughnessy, John D., Jr.
    Barlogie, Bart
    Sanderson, Ralph D.
    BLOOD, 2007, 110 (06) : 2041 - 2048
  • [43] Nucleolin is a nuclear target of heparan sulfate derived from glypican-1
    Cheng, Fang
    Belting, Mattias
    Fransson, Lars-Ake
    Mani, Katrin
    EXPERIMENTAL CELL RESEARCH, 2017, 354 (01) : 31 - 39
  • [44] The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans
    Hassan, Nourhan
    Efing, Janes
    Kiesel, Ludwig
    Bendas, Gerd
    Goette, Martin
    CANCERS, 2023, 15 (05)
  • [45] A Thermally Stable Form of Bacterial Cocaine Esterase: A Potential Therapeutic Agent for Treatment of Cocaine Abuse
    Brim, Remy L.
    Nance, Mark R.
    Youngstrom, Daniel W.
    Narasimhan, Diwahar
    Zhan, Chang-Guo
    Tesmer, John J. G.
    Sunahara, Roger K.
    Woods, James H.
    MOLECULAR PHARMACOLOGY, 2010, 77 (04) : 593 - 600
  • [46] REGULATION BY HEPARAN-SULFATE IN FIBROBLAST GROWTH-FACTOR SIGNALING
    RAPRAEGER, AC
    GUIMOND, S
    KRUFKA, A
    OLWIN, BB
    EXTRACELLULAR MATRIX COMPONENTS, 1994, 245 : 219 - 240
  • [47] Role of heparan sulfate in fibroblast growth factor signalling: a structural view
    Pellegrini, L
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2001, 11 (05) : 629 - 634
  • [48] Growth factor–heparan sulfate “switches” regulating stages of branching morphogenesis
    Sanjay K. Nigam
    Kevin T. Bush
    Pediatric Nephrology, 2014, 29 : 727 - 735
  • [49] A hepatocyte growth factor antagonist engineered by disruption of heparan sulfate binding
    Cecchi, Fabiola
    Pajalunga, Deborah
    Rabe, Daniel C.
    Peruzzi, Benedetta
    Fowler, Andrew C.
    Blackman, Davida K.
    MacDonald, Nicholas
    Stahl, Stephen J.
    Byrd, Andrew R.
    Bottaro, Donald P.
    CANCER RESEARCH, 2010, 70
  • [50] Characterization of fibroblast growth factor 1 binding heparan sulfate domain
    Kreuger, J
    Prydz, K
    Pettersson, RF
    Lindahl, U
    Salmivirta, M
    GLYCOBIOLOGY, 1999, 9 (07) : 723 - 729